The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpmorgan Glbl E Regulatory News (JARE)

Share Price Information for Jpmorgan Glbl E (JARE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.82
Bid: 0.75
Ask: 0.89
Change: 0.00 (0.00%)
Spread: 0.14 (18.667%)
Open: 0.82
High: 0.82
Low: 0.82
Prev. Close: 0.82
JARE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Dividend Declaration and Update

23 Apr 2020 15:02

RNS Number : 6975K
JPMorgan Global Core Real Assets Ld
23 April 2020
 

LONDON STOCK EXCHANGE ANNOUNCEMENT

 

JPMORGAN GLOBAL CORE REAL ASSETS LIMITED

(the "Company" or "JARA")

 

DIVIDEND DECLARATION AND UPDATE

 

 

Legal Entity Identifier: 549300D8JHZTH6GI8F97

Information disclosed in accordance with DTR 6.1.13

 

Second Quarterly Interim Dividend

 

The Directors have declared a second quarterly interim dividend of 0.75p per share, to be paid on 28th May 2020 to shareholders on the register as at the close of business on 1st May 2020. The ex-dividend date will be 30th April 2020. The Company's first quarterly dividend of 0.75 pence per share was paid on 27th February 2020.

 

· As detailed in the Prospectus, the Company is targeting a dividend yield on the Ordinary Shares of 2% to 3%. (on the basis of the Initial Issue Price), in the first 12 months from the date of Initial Admission. Post this second dividend, the Company will have paid 1.5p per share since its 24th September 2019 IPO and remains on track to meet its dividend target.

· The Company has so far invested approximately 40% of the proceeds arising from its IPO and from subsequent share issuance. The current turmoil in financial markets has meant capital has been drawn down slower than originally intended, but we remain on course be in fully invested at or around 12 months from IPO as stated in the Prospectus. Importantly, this does not impact the Company's long term return assumptions and may in fact provide a benefit.

· In the short term, due to the fall in money market rates, the interest income which the Company is receiving on its near cash instruments has declined as rate cuts in response to the coronavirus pandemic have reduced the yields available on these instruments.

· While, in the short term, this means the Company's liquidity is higher than planned, the Manager views this as a net positive as it provides the opportunity to deploy cash into investments at lower prices, and therefore higher yields, providing longer term support to the dividend.

 

These effects mean there is a short term reduction in the income account and, until further capital is drawn into the underlying strategies, the Directors intend to maintain the current level of dividend payments, supplementing the Company's earnings by using the reserves accumulated in the share premium account which, following payment of the second interim dividend, will stand at approximately 1.62 pence per share. The Directors therefore see no immediate threat to the level of quarterly dividends being paid, but they recognise that, in the longer term, their ability to maintain and grow the dividend will depend on the rate at which the fund can invest and in the continuing success of the underlying strategies.

 

In summary, despite current market conditions, with the proposed drawdown profile of the underlying strategies, the Company remains on track to hit full deployment at or around the 12 month point, as outlined in the Prospectus. Importantly, given the growth of JARA and reduction in fees and ongoing costs, we remain comfortably able to achieve the long term target of 4% - 6% income on issue price for the second 12 month period and current market conditions could allow a potentially attractive entry point for the Company's capital to help support the long term total returns of 7% - 9%.

 

In due course, an update will be provided to investors on the progress of the Company's investment portfolio.

 

 

23rd April 2020

 

 

For further information:

 

Alison Vincent

JPMorgan Funds Limited

Company Secretary

 

020 7742 4000

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DIVUOVORRKUSUAR
Date   Source Headline
3rd Oct 202212:14 pmRNSTotal Voting Rights
20th Sep 20223:30 pmRNSClosed Period Notification
20th Sep 20227:00 amRNSQuarterly Net Asset Value and Portfolio Update
9th Sep 202210:03 amRNSBlock Listing Return
1st Sep 202211:55 amRNSTotal Voting Rights
17th Aug 20225:40 pmRNSIssue of Equity (Replacement)
17th Aug 20224:34 pmRNSIssue of Equity
9th Aug 202210:14 amRNSDirector/PDMR Shareholding (Replacement)
9th Aug 20227:00 amRNSNet Asset Value (monthly)
8th Aug 20225:33 pmRNSDirector/PDMR Shareholding (Replacement)
8th Aug 20224:55 pmRNSDirector/PDMR Shareholding
5th Aug 202212:51 pmRNSResult of AGM
22nd Jul 20227:00 amRNSDividend Declaration
8th Jul 20221:43 pmRNSHolding(s) in Company
8th Jul 20227:00 amRNSNet Asset Value (monthly)
4th Jul 20227:00 amRNSFinal Results
16th Jun 20228:10 amRNSNet Asset Value and Update
26th Apr 202211:08 amRNSHolding(s) in Company
25th Apr 20229:00 amRNSDividend Declaration
21st Apr 20227:00 amRNSCapital Call
21st Mar 202210:07 amRNSClosed Period Notification
18th Mar 20227:00 amRNSQuarterly Net Asset Value and Portfolio Update
9th Mar 20227:18 amRNSBlock Listing Return
4th Mar 20227:00 amRNSCapital Call and Portfolio Update
20th Jan 202212:12 pmRNSDividend Declaration
17th Jan 20227:00 amRNSFee Reduction
14th Dec 20217:00 amRNSNET ASSET VALUE AND PORTFOLIO UPDATE - QUARTERLY
16th Nov 20217:00 amRNSHalf-Year Results 2021
15th Oct 202111:00 amRNSDividend Declaration
5th Oct 20215:00 pmRNSClosed Period Notification
21st Sep 20217:00 amRNSQuarterly Net Asset Value and Portfolio Update
9th Sep 20217:00 amRNSBlock listing Interim Review
31st Aug 20215:34 pmRNSTotal Voting Rights
12th Aug 20214:37 pmRNSIssue of Equity
3rd Aug 20211:04 pmRNSResult of AGM
30th Jul 20216:00 pmRNSTotal Voting Rights
28th Jul 20214:48 pmRNSIssue of Equity
21st Jul 20217:00 amRNSIssuance and Investment Update
15th Jul 20214:56 pmRNSIssue of Equity
14th Jul 20214:54 pmRNSIssue of Equity
12th Jul 20217:00 amRNSInvestment Update
8th Jul 20217:03 amRNSFinal Results
9th Jun 20217:00 amRNSQuarterly Net Asset Value and Portfolio Update
28th May 202110:00 amRNSChange of Broker
25th May 20217:00 amRNSInvestment Update
24th May 20211:34 pmRNSClosed Period Notification
15th Apr 20215:03 pmRNSDirector/PDMR Shareholding
23rd Mar 20217:00 amRNSQuarterly NAV and Disclosure Update
11th Mar 20212:24 pmRNSProspectus - Long Stop Date
3rd Feb 20217:00 amRNSCapital Call and C Share Capital Raise Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.